You are using an older browser version. Please use a supported version for the best MSN experience.

Bharat Biotech’s COVAXIN gets nod for phase 2/3 trials on 2-18 years old

As per the official sources, the trial for the vaccine will take place in 525 subjects at different sites, including AIIMS, Patna, AIIMS, Delhi, and Meditrina Institute of Medical Sciences, Nagpur.
image beaconimage beaconimage beacon